Source: Institutional Research Information System (IRIS)
Negrini M; Cutrona G; Bassi C; Fabris S; Zagatti B; Colombo M; Ferracin M; D'Abundo L; Saccenti E; Matis S; Lionetti M; Agnelli L; Gentile M; Recchia AG; Bossio S; Reverberi D; Rigolin G; Calin GA; Sabbioni S; Russo G; Tassone P; Morabito F; Ferrarini M; Neri A., microRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters, «CLINICAL CANCER RESEARCH», 2014, 20, pp. 4141 - 4153 [Scientific article]
Potrich C; Vaghi V; Lunelli L; Pasquardini L; Santini GC; Ottone C; Quaglio M; Cocuzza M; Pirri CF; Ferracin M; Negrini M; Tiberio P; De Sanctis V; Bertorelli R; Pederzolli C, OncomiR detection in circulating body fluids: a PDMS microdevice perspective., «LAB ON A CHIP», 2014, 14, pp. 4067 - 4075 [Scientific article]
M. Ferracin; L. Lupini, MicroRNA Expression Profiling and Its Clinical Impact in Breast Cancer, in: MicroRNAs: Key Regulators of Oncogenesis, Switzerland, Springer International Publishing, 2014, pp. 355 - 367 [Chapter or essay]
Ciancio, Giovanni; Volpinari, Stefania; Fotinidi, Maria; Furini, Federica; Farina, Ilaria; Bortoluzzi, Alessandra; Ferracin, Manuela; Bandinelli, Francesca; Orzincolo, Carlo; Trotta, Francesco; Govoni, Marcello, Involvement of the inconstant bursa of the fifth metatarsophalangeal joint in psoriatic arthritis: A clinical and ultrasonographic study, «BIOMED RESEARCH INTERNATIONAL», 2014, 2014, pp. 174841 - 174841 [Scientific article] Open Access
Barriere G.; Fici P.; Gallerani G.; Fabbri F.; Zoli W.; Rigaud M., Circulating tumor cells and epithelial, mesenchymal and stemness markers: Characterization of cell subpopulations, «ANNALS OF TRANSLATIONAL MEDICINE», 2014, 2, pp. 109 - 116 [Review]
Lupini L.; Bassi C.; Ferracin M.; Bartonicek N.; D'Abundo L.; Zagatti B.; Callegari E.; Musa G.; Moshiri F.; Gramantieri L.; Corrales F.J.; Enright A.J.; Sabbioni S.; Negrini M., miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs, «FRONTIERS IN GENETICS», 2013, 4, pp. 64 - 64 [Scientific article]
M. Ferracin; C. Bassi; M. Pedriali; S. Pagotto; L. D’Abundo; B. Zagatti; F. Corrà; G. Musa; E. Callegari; L. Lupini; S. Volpato; P. Querzoli; M. Negrini, miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression, «MOLECULAR CANCER», 2013, 12, pp. 130 - 130 [Scientific article]
Wang LQ; Kwong YL; Kho CS; Wong KF; Wong KY; Ferracin M; Calin GA; Chim CS, Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NFκB pathway., «MOLECULAR CANCER», 2013, 12, pp. 1 - 1 [Scientific article]
Chillemi A; Zaccarello G; Quarona V; Ferracin M; Ghimenti C; Massaia M; Horenstein AL; Malavasi F, Anti-CD38 antibody therapy: windows of opportunity yielded by the functional characteristics of the target molecule., «MOLECULAR MEDICINE», 2013, 19, pp. 99 - 108 [Scientific article]
Sciamanna I; Gualtieri A; Cossetti C; Osimo EF; Ferracin M; Macchia G; Aricò E; Prosseda G; Vitullo P; Misteli T; Spadafora C, A tumor-promoting mechanism mediated by retrotransposon-encoded reverse transcriptase is active in human transformed cell lines., «ONCOTARGET», 2013, 4, pp. 2271 - 2287 [Comment or similar]